Asia vs Bolivia (Plurinational State of): Proportion of the target population who received the final dose of
Asia
14.0%
in 2024
Bolivia (Plurinational State of)
78.0%
in 2024
Asia rank
28th
Bolivia (Plurinational State of) rank
28th
Proportion of the target population who received the final dose of over time
- Asia
- Bolivia (Plurinational State of)
How they compare
Bolivia (Plurinational State of) currently reports 78.0% against 14.0% in Asia, a difference of 64.0%.
That makes Bolivia (Plurinational State of)'s figure about 5.6 times Asia's.
Across all 8 years both countries report, Bolivia (Plurinational State of) has been ahead every year.
Asia ranks 28th and Bolivia (Plurinational State of) ranks 28th of 35 groups.
Bolivia (Plurinational State of) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Asia | Bolivia (Plurinational State of) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.0% | 64.0% | 62.0% | Bolivia (Plurinational State of) |
| 2020s | 6.0% | 49.8% | 43.8% | Bolivia (Plurinational State of) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Asia or Bolivia (Plurinational State of)?
- Bolivia (Plurinational State of), at 78.0% against 14.0% in Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Asia and Bolivia (Plurinational State of)?
- 64.0%, with Bolivia (Plurinational State of) ahead.
- How many years of comparable data are there for Asia and Bolivia (Plurinational State of)?
- 8 years are reported by both, from 2017 to 2024.
- How do Asia and Bolivia (Plurinational State of) rank globally for proportion of the target population who received the final dose of?
- Asia ranks 28th and Bolivia (Plurinational State of) ranks 28th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.